For the year ending 2025-12-31, PCRX has $1,264,917K in assets. $571,806K in debts. $158,545K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 158,545 | |||
| Short-term available-for-sale investments | 79,879 | |||
| Accounts receivable, net | 124,069 | |||
| Inventories, net | 152,863 | |||
| Prepaid expenses and other current assets | 32,618 | |||
| Total current assets | 547,974 | |||
| Fixed assets, net | 140,690 | |||
| Right-of-use assets, net | 41,777 | |||
| Goodwill | 20,214 | |||
| Intangible assets, net | 368,100 | |||
| Deferred tax assets | 123,854 | |||
| Investments and other assets | 22,308 | |||
| Total assets | 1,264,917 | |||
| Accounts payable | 15,150 | |||
| Accrued expenses | 95,601 | |||
| Lease liabilities | 9,839 | |||
| Current portion of long-term debt, net | 0 | |||
| Total current liabilities | 120,590 | |||
| Long-term debt, net | 372,189 | |||
| Lease liabilities | 36,176 | |||
| Contingent consideration | 18,066 | |||
| Deferred tax liabilities | 4,213 | |||
| Other liabilities | 20,572 | |||
| Total liabilities | 571,806 | |||
| Common stock, par value 0.001 250,000,000 shares authorized 47,890,777 shares issued and 41,116,739 shares outstanding at december31, 2025 and 47,077,844 shares issued and 46,240,604 shares outstanding at december31, 2024 | 48 | |||
| Treasury stock, at cost, inclusive of excise tax and broker fees, 6,774,038 and 837,240 shares at december31, 2025 and 2024, respectively | 176,565 | |||
| Additional paid-in capital | 1,064,623 | |||
| Accumulated deficit | -199,322 | |||
| Accumulated other comprehensive income | 4,327 | |||
| Total stockholders equity | 693,111 | |||
| Total liabilities and stockholders equity | 1,264,917 | |||
Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. (PCRX)